2nd Quarter - Termination
STEPTOE LLP for AQUESTIVE THERAPEUTICS, INC.
Firm
Client
Income
$30,000
Expenses
—
Terminated
Apr 22, 2025
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Issues related to the FDA and the Orphan Drug Program.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JASON ABEL | — |
| LESLIE BELCHER | — |
| JACK BUTTARAZZI | — |
| MATTHEW FLYNN | — |
| MICHELE NELLENBACH | — |
Pharmacy PHA
Issues related to the FDA and the Orphan Drug Program.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JASON ABEL | — |
| LESLIE BELCHER | — |
| JACK BUTTARAZZI | — |
| MATTHEW FLYNN | — |
| MICHELE NELLENBACH | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.